Stay updated with breaking news from Quantitative Medicine Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Critical Path Institute's (C-Path) Duchenne Regulatory Science Consortium (D-RSC) is excited to announce the launch of a groundbreaking...
/PRNewswire/ -- Critical Path Institute (C-Path) has named Klaus Romero, M.D., M.S., FCP, as its new Chief Executive Officer and promoted Cécile Ollivier,...
/PRNewswire/ -- Critical Path Institute (C-Path) today announced that Klaus Romero, M.D., M.S., FCP, has been named its new Chief Executive Officer. Romero, a...
C-Path and Tufts Medical Center have announced a joint venture to integrate the first patient-level clinical trial data to generate actionable real-world evidence for neonatal drug development, from real-world neonate data. This activity, funded by the FDA, is being executed through a neonatal pilot project within C-Path's International Neonatal Consortium.